Quilvest Acquires Majority Interest in UrgentMED

Quilvest Capital Partners (“Quilvest”), a leading global private investment firm, is announced that it has made a substantial growth investment in UrgentMED, the premier independent network of urgent care clinics in Southern California. Quilvest is partnering with UrgentMED’s co-founders, Dr. Jacob Rastegar, Dr. Morris Kokhab, and Dr. Pejman Bolourian, who will each remain significant shareholders and will continue to lead the business going forward.  The financial terms of the transaction were not disclosed.

Founded in 2007 and headquartered in West Hollywood, California, UrgentMED operates 35 urgent care clinics in the Southern California region, including Los Angeles County, Orange County and Ventura County.

“We are thrilled to partner with Drs. Rastegar, Kokhab and Bolourian,” said Jay Takefman, Partner and Co-Head of Direct Private Equity at Quilvest. “UrgentMED has established itself as the leading independent urgent care network in Southern California and is ideally positioned to meet consumers’ and payors’ demands for convenient, affordable and high-quality care by deploying its broad healthcare offering across its clinic footprint. We look forward to joining UrgentMED on the next phase of its journey as the company continues its growth strategy,” he added.

Dr. Rastegar, Dr. Kokhab and Dr. Bolourian (co-founders and co-CEOs), stated: “We welcome the Quilvest team to the UrgentMED family. Quilvest is an ideal partner for us due to its deep understanding of multi-unit business models, healthcare sector expertise and vast network of resources to help us grow.  We are excited to have a supportive partner who shares our vision.”

Benjamin Sass, Principal at Quilvest, added: “UrgentMED is an exceptional business led by an exceptional team. We look forward to helping UrgentMED accelerate its expansion strategy, while continuing to leverage UrgentMED’s patient-centric model and culture of care.”

Quilvest was advised by Piper Sandler and Dechert LLP. UrgentMED was advised by FocalPoint Securities LLC and Sheppard, Mullin, Richter & Hampton.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.